Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)
India flag India · Delayed Price · Currency is INR
474.35
-8.65 (-1.79%)
At close: Mar 6, 2026

NSE:AKUMS Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
72,62474,479----
Enterprise Value
57,18071,969----
Last Close Price
474.35473.20----
PE Ratio
22.8322.02----
PS Ratio
1.701.81----
PB Ratio
2.292.43----
P/TBV Ratio
2.312.45----
P/FCF Ratio
-38.61----
P/OCF Ratio
-16.01----
EV/Sales Ratio
1.341.75----
EV/EBITDA Ratio
11.6715.76----
EV/EBIT Ratio
17.8122.60----
EV/FCF Ratio
-37.31----
Debt / Equity Ratio
0.030.030.790.860.640.15
Debt / EBITDA Ratio
0.180.191.162.070.980.45
Debt / FCF Ratio
-0.463.03--2.75
Net Debt / Equity Ratio
-0.49-0.160.400.650.480.05
Net Debt / EBITDA Ratio
-3.28-1.070.601.630.740.16
Net Debt / FCF Ratio
--2.531.54-3.11-1.320.94
Asset Turnover
-1.081.231.151.40-
Inventory Turnover
-3.813.853.244.19-
Quick Ratio
-1.510.920.800.781.07
Current Ratio
-2.551.601.521.492.00
Return on Equity (ROE)
-18.17%0.11%14.51%-33.18%-
Return on Assets (ROA)
-5.22%6.72%3.74%7.54%-
Return on Invested Capital (ROIC)
19.34%17.70%33.07%11.64%34.07%17.35%
Return on Capital Employed (ROCE)
-9.90%15.80%9.50%17.60%14.20%
Earnings Yield
4.38%4.54%----
FCF Yield
-2.59%----
Buyback Yield / Dilution
-4.01%-4.58%----
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.